|
"shih j y"的相关文件
显示项目 1051-1060 / 1137 (共114页)
<< < 101 102 103 104 105 106 107 108 109 110 > >>
每页显示[10|25|50]项目
| 臺大學術典藏 |
2018 |
Response to Stephane Renaud et al.
|
Hsu F.-M.; CHAO-CHI HO; Yang W.-C.; Shih J.-Y. |
| 臺大學術典藏 |
2018 |
Response to Stephane Renaud et al.
|
Yang W.-C.;Shih J.-Y.;Chao-Chi Ho;Hsu F.-M.; Yang W.-C.; Shih J.-Y.; CHAO-CHI HO; Hsu F.-M. |
| 臺大學術典藏 |
2018 |
Driver mutations of young lung adenocarcinoma patients with malignant pleural effusion
|
Shih J.-Y.; Yang J.C.-H.; Yu C.-J.; Liu Y.-N.; SHANG-GIN WU; Shang-Gin Wu;Liu Y.-N.;Yu C.-J.;Yang J.C.-H.;Shih J.-Y. |
| 臺大學術典藏 |
2018 |
Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan
|
Lin S.-Y.;Yang C.-Y.;Liao B.-C.;Ho C.-C.;Liao W.-Y.;Chen K.-Y.;Tsai T.-H.;Chia-Lin Hsu;Hsu W.-H.;Su K.-Y.;Chang Y.-L.;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.;Yu C.-J.; Lin S.-Y.; Yang C.-Y.; Liao B.-C.; Ho C.-C.; Liao W.-Y.; Chen K.-Y.; Tsai T.-H.; CHIA-LIN HSU; Hsu W.-H.; Su K.-Y.; Chang Y.-L.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.; Yu C.-J. |
| 臺大學術典藏 |
2018 |
Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: A real-world, large cohort study
|
Liao W.-Y.; MENG-RUI LEE; Liang S.-K.; Ho C.-C.; Ko J.-C.; Shih J.-Y. |
| 國立成功大學 |
2018 |
In-hospital implementation of evidence-based, medications is associated with improved survival, in diabetic patients with acute coronary, syndrome - Data from TSOC ACS-DM registry
|
Chen, K.-C.;Yin, W.-H.;Wu, C.-C.;Chan, S.-H.;Wu, Y.-W.;Wang, K.Y.;Chang, K.-C.;Hwang, J.-J.;Voon, W.-C.;Hsieh, I.-C.;Chong, J.-T.;Lin, W.-S.;Hsu, C.-N.;Ueng, K.-C.;Hsia, C.-P.;Liu, J.-C.;Yeh, J.-S.;Mar, G.-Y.;Shih, J.-Y.;Kuo, J.-Y.;Tsao, H.-M.;Tseng, W.-K.;Yang, C.-H.;Chang, Chang C.-C.;Chiang, Chiang C.-E.;Lei, M.-H.;Lin, J.-F.;Shyu, K.-G. |
| 國立成功大學 |
2018 |
Ramucirumab safety in East Asian patients: A meta-analysis of six global, randomized, double-blind, placebo-controlled, phase III clinical trials
|
Yen, C.-J.;Muro, K.;Kim, T.-W.;Kudo, M.;Shih, J.-Y.;Lee, K.-W.;Chao, Y.;Kim, S.-W.;Yamazaki, K.;Sohn, J.;Cheng, R.;Zhang, Y.;Binder, P.;Mi, G.;Orlando, M.;Chung, H.C. |
| 國立臺灣科技大學 |
2017 |
Mechanical properties and microstructural analysis of slag based cementitious binder with calcined dolomite as an activator
|
Djayaprabha, H.S;Chang, T.-P;Shih, J.-Y;Chen, Chen C.-T. |
| 國立臺灣科技大學 |
2017 |
Life cycle guideline of petrochemical plant underground piping system
|
Shih, J.-Y.;Hsiao, S.-Y.;Chang, T.-P. |
| 臺大學術典藏 |
2017 |
Lung adenocarcinoma patients of young age have lower EGFR mutation rate and poorer efficacy of EGFR tyrosine kinase inhibitors
|
Wu S.-G.;Yih-Leong Chang;Yu C.-J.;Yang P.-C.;Shih J.-Y.; Wu S.-G.; YIH-LEONG CHANG; Yu C.-J.; Yang P.-C.; Shih J.-Y. |
显示项目 1051-1060 / 1137 (共114页)
<< < 101 102 103 104 105 106 107 108 109 110 > >>
每页显示[10|25|50]项目
|
